ICECURE MEDICAL (Israel) Today

Equity ratings for ICECURE MEDICAL LT are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of September 2019 and ending today, the 19th of September 2021. Click here to learn more.
ICECURE MEDICAL LT cannot be verified against its exchange. It appears that ICECURE MEDICAL is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

ICECURE MEDICAL Stock Profile

IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for womens health and oncology markets. IceCure Medical Ltd was founded in 2006 and is based in Caesarea, Israel. ICECURE MEDICAL is traded on Tel Aviv Stock Exchange in Israel.. The public information regarding ICECURE MEDICAL LT's current market price is not available at this time.
ICECURE MEDICAL LT is not yet fully synchronised with the market data
ICECURE MEDICAL LT has some characteristics of a very speculative penny stock
ICECURE MEDICAL LT has a very high chance of going through financial distress in the upcoming years
ICECURE MEDICAL LT has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported the revenue of 4.04 M. Net Loss for the year was (13.31 M) with profit before overhead, payroll, taxes, and interest of 1.69 M.
ICECURE MEDICAL LT has accumulated about 15.79 M in cash with (11.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15.
Legal NameICECURE MEDICAL LT
CEO, DirectorEyal Shamir  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ICECURE MEDICAL's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
ICECURE MEDICAL LT (ICCM) is traded on Tel Aviv Stock Exchange in Israel and employs 4 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 6.33 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ICECURE MEDICAL's market, we take the total number of its shares issued and multiply it by ICECURE MEDICAL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ICECURE MEDICAL LT operates under Healthcare sector and is part of Medical Care industry. The entity has 105.78 M outstanding shares. ICECURE MEDICAL LT has accumulated about 15.79 M in cash with (11.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15.
Check ICECURE MEDICAL Probability Of Bankruptcy

ICECURE Stock Against Markets

Picking the right benchmark for ICECURE MEDICAL stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ICECURE MEDICAL stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ICECURE MEDICAL is critical whether you are bullish or bearish towards ICECURE MEDICAL LT at a given time.
ICECURE MEDICAL LT cannot be verified against its exchange. It appears that ICECURE MEDICAL is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ICECURE MEDICAL stock to make a market-neutral strategy. Peer analysis of ICECURE MEDICAL could also be used in its relative valuation, which is a method of valuing ICECURE MEDICAL by comparing valuation metrics with similar companies.
Check out Risk vs Return Analysis. Note that the ICECURE MEDICAL LT information on this page should be used as a complementary analysis to other ICECURE MEDICAL's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Tools for ICECURE Stock

When running ICECURE MEDICAL LT price analysis, check to measure ICECURE MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICECURE MEDICAL is operating at the current time. Most of ICECURE MEDICAL's value examination focuses on studying past and present price action to predict the probability of ICECURE MEDICAL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ICECURE MEDICAL's price. Additionally, you may evaluate how the addition of ICECURE MEDICAL to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go